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Abstract
Background: The prevalence of carcinoma in main-duct intraductal papillary mucinous neoplasm (IPMN) is high,
and surgical resection is recommended for all patients with a main-duct IPMN.
Results: A main-duct IPMN with typical imagings including protruding lesions in the dilated main pancreatic duct
was resected, but the histology was intraductal papillary mucinous adenoma of the pancreas.
Discussion: It has been reported that the presence of mural nodules and dilatation of MPD are significantly higher
in malignant IPMNs. The presented case had protruding lesions in the dilated main pancreatic duct on endoscopic
ultrasonography, but the histology was adenoma.
Conclusion: Preoperative distinction between benign and malignant IPMNs is difficult.
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Background
Intraductal papillary mucinous neoplasm (IPMN) of the
pancreas is a distinct entity characterized by intraductal
papillary growth and thick mucus secretion. Copious
mucous fills the main and branch pancreatic ducts and
causes ductal dilation. Thus, IPMNs of the pancreas are
being diagnosed with increasing frequency by radiologic
findings.
IPMNs are pathologically classified into two types based
on site of tumor involvement, that is, main-duct type or
branch type. The histology is classified into intraductal
adenocarcinoma, intraductal adenoma, and hyperplasia. It
has been suggested that these lesions have the capacity to
progress from hyperplasia to adenoma, to noninvasive car-
cinoma, and ultimately to invasive carcinoma. The preva-
lence of carcinoma in main-duct IPMN is as high as 60%
[1] to 92% [2], and international consensus guidelines [3]
recommend surgical resection for all patients with a main-
duct IPMN. In preoperative diagnosis, it is evaluated the
existence of mural nodule increase the risk of malignancy
[3-5]. Whereas, there are various unanswered problems
about the conditions of main-duct type IPMNs. It is
unknown whether all IPMNs have malignant potential or
what the time course of progression may be.
Case presentation
A 56-year-old man presented with mild abdominal pain.
Physical examination and laboratory data were unremark-
able. Abdominal symptoms were relieved with conservative
medical management within a few days. Abdominal ultra-
sonography showed dilation of the main pancreatic duct
(MPD). Subsequent computed tomography scan showed
dilatation of the MPD and several small cysts in the
pancreatic tail, with no findings of mural nodules, mass
formation, metastasis, or lymph node swelling. Magnetic
resonance cholangiopancreatography (MRCP) showed an
irregular dilatation (10 mm) of the MPD of the tail [Figure
1]. On duodenoscopy, mucin was secreted from a patulous
orifice of the papilla of Vater. On endoscopic retrograde
pancreatography, a filling defect equivalent to mucus was
shown in the dilated MPD. Cytological examination of the
pancreatic fluid was negative, and CEA level in the pan-
creatic fluid was 2.3 ng/ml. Endoscopic ultrasonography
(EUS) revealed hyperplastic or polypoid growth of the
epithelial layer and hyperechoic ductal margin of the irre-
gularly dilated MPD [Figure 2]. Under a diagnosis of main-
duct IPMN, laparoscopy-assisted distal pancreatectomy
was performed. Cut surface of the resected specimen
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any medium, provided the original work is properly cited.revealed hyperplastic or polypoid lesions developed in the
markedly thickened wall of the MDP [Figure 3]. Histologi-
cally, the tumor was classified as intraductal papillary muci-
nous adenoma extensively proliferating in the MPD, and
the surgical margin was free. Immunohistochemically, Ki-
67 labeling index was 1.8% and p53-positive cells were not
observed in the tumor cells. Fibrotic lesions with acinar
atrophy surrounded the MPD [Figure 4].
Discussion
IPMN is an increasingly recognized entity representing a
spectrum of benign and malignant neoplasms of the
pancreas. International consensus guidelines [3] recom-
mend surgical resection for all patients with a main-
duct IPMN because of high potential for complication
of malignancy.
It has been reported that the presence of mural
nodules and dilatation of MPD are significantly higher
in malignant IPMNs [3]. We also reported MPD dia-
meter ≥ 10 mm and appearance of mural nodules were
significantly more frequent in malignant IPMNs [4].
Sugiyama et al. reported that presence of symptoms,
MPD diameter > 15 mm, and mural nodules were sig-
nificant predictors of malignancy in main-duct or mixed
type IPMNs [5]. In Sang et al. report, multivariate analy-
sis showed that age more than 60 years, history of pan-
creatitis, presence of mural nodules, MPD dilatation > 6
mm were independent predictors of invasive IPMNs [6].
However, there were some typical main-duct IPMN
Figure 1 MRCP of the case. MRCP showing an irregular dilatation
(10 mm) of the main pancreatic duct of the tail.
Figure 2 EUS of the case. EUS showing hyperplastic or a polypoid
growth of the epithelial layer (arrows) and hyperechoic ductal
margin (arrow heads) of the irregularly dilated main pancreatic duct.
Figure 3 Cut surface of the resected specimen.C u ts u r f a c eo f
the resected specimen showing hyperplastic or polypoid lesions
(arrows) developed in the markedly thickened wall of the main
pancreatic duct.
Figure 4 Histology of the tumor. Histologically, the tumor was
classified as an intraductal papillary mucinous adenoma extensively
proliferating in the main pancreatic duct. Fibrotic lesions with acinar
atrophy surrounded the main pancreatic duct.
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could be followed-up for long term [3-5,7].
EUS is one of the most useful modalities to evaluation
local changes in the pancreas. Intraductal papillary adeno-
carcinoma is characterized by papillary protrusions and
thick septum like structures in a dilated duct as delineated
by EUS. When the thickness of the septum structure is
more than 4 mm on EUS, neoplastic change should be
suspected. Finding of solid mass or a mass showing a
mixed-echo pattern in the pancreatic parenchyma are
characteristic of the invasive type of IPMN [8].
The present case was a typical main-duct IPMN, and
EUS showed its entire picture. Although the case had
mural nodules and the dilated MPD which were indicators
of possible malignancy, the histology was intraductal papil-
lary mucinous adenoma. For the high prevalence of carci-
noma in main-duct IPMNs, international consensus
guidelines that recommend surgical resection for all
patients with a main-duct IPMN are considered reason-
able and proper. As it stands now, although the histology
was adenoma, resection was considerable based on the
patient’ s age and adenoma-carcinoma sequence. Preo-
perative distinction between benign and malignant IPMNs
remains difficult.
Conclusion
Preoperative distinction between benign and malignant
IPMNs remains difficult.
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